Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Gainers

  • Recruiter.com Group, Inc. (NASDAQ:RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.
  • Hoth Therapeutics, Inc. (NASDAQ:HOTH) rose 96% to $3.6850 after the company announced preclinical results for HT-ALZ for the treatment of Alzheimer's disease.
  • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) shares rose 37.8% to $0.5928.
  • Zura Bio Limited (NASDAQ:ZURA) shares gained 25% to $8.11 after the company completed approximately $80 million financing with the focus on advancing ZB-106, a potential first-in-class anti-IL-17 and anti-BAFF dual antagonist.
  • Xunlei Limited (NASDAQ:XNET) rose 22% to $1.6715. Xunlei launched a $20 million share buyback program.
  • G-III Apparel Group, Ltd. (NASDAQ:GIII) gained 21.7% to $20.13 following first-quarter results. G-III Apparel reported a master licensing partnership with Xcel Brands to design and produce all categories and distribute products globally for the Halston business and all of its brands.
  • GT Biopharma, Inc. (NASDAQ:GTBP) rose 20.7% to $0.35.
  • Secoo Holding Limited (NASDAQ:SECO) gained 20.2% to $0.9739.
  • GitLab Inc. (NASDAQ:GTLB) shares climbed 19.9% to $42.43 after the company reported better-than-expected first-quarter results. Multiple analysts raised their price targets on the stock following the report.
  • Big Lots, Inc. (NYSE:BIG) gained 18.1% to $6.97.
  • Chijet Motor Company, Inc. (NASDAQ:TTOO) shares surged 18.1% to $0.0827after dipping around 31% on Monday. T2 Biosystems reported submission for the FDA breakthrough device designation for candida auris diagnostic test.
  • Castle Biosciences, Inc. (NASDAQ:CSTL) gained 18.8% to $13.86. Canaccord Genuity maintained Castle Biosciences with a Buy and lowered the price target from $60 to $40.
  • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 17% to $0.1478. Novo Integrated Sciences recently posted a first-quarter loss of 12 cents per share.
  • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) gained 16.4% to $0.2213.
  • MicroVision, Inc. (NASDAQ:MVIS) gained 15.3% to $6.14.
  • PARTS iD, Inc. (NYSE:ID) climbed 15.3% to $0.4070.
  • AlloVir, Inc. (NASDAQ:ALVR) gained 15.3% to $5.15.
  • THOR Industries, Inc. (NYSE:THO) rose 14.6% to $90.69 after the company reported better-than-expected third-quarter results and raised its FY23 EPS guidance.
  • Synlogic, Inc. (NASDAQ:SYBX) gained 14.3% to $0.5601. HC Wainwright & Co. reiterated Synlogic with a Buy and maintained a $5 price target.
  • Outlook Therapeutics, Inc. (NASDAQ:OTLK) gained 11.7% to $1.9550.
  • HealthEquity, Inc. (NASDAQ:HQY) rose 11.3% to $65.51 following strong quarterly results.
  • Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) climbed 9.2% to $17.25.
  • FiscalNote Holdings, Inc. (NYSE:NOTE) gained 9% to $2.55.
  • Stem, Inc. (NASDAQ:STEM) gained 7.7% to $6.00. Janney Montgomery Scott initiated coverage on Stem with a Buy rating and announced a price target of $12.
  • Sprinklr, Inc. (NYSE:CXM) climbed 7.5% to $14.52 after the company reported better-than-expected earnings and sales results for its first quarter.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares climbed 7.3% to $2.7250. Lexicon Pharmaceuticals 10% owner Invus Advisors LLC acquired a total 27,775,050 shares an average price of $2.60.

Losers

  • Tingo Group, Inc. (NASDAQ:TIO) shares fell 52.8% to $1.2050. A short report from Hindenburg Research has hit Tingo Group, calling it an "exceptionally obvious scam" with alleged falsified financials.
  • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) fell 40.3% to $1.00 after dropping over 20% on Monday.
  • JOANN Inc. (NASDAQ:JOAN) fell 28.7% to $1.1473 following weak quarterly results.
  • NovoCure Limited (NASDAQ:NVCR) fell 28.5% to $59.02. NovaCure disclosed results from the Phase 3 LUNAR clinical trial evaluating the use of tumor treating fields therapy with standard treatment therapies and said it met its primary endpoint at 2023 ASCO Annual Meeting.
  • Wejo Group Limited (NASDAQ:WEJO) shares declined 25.6% to $0.0632.
  • Ucommune International Ltd (NASDAQ:UK) shares dropped 23.5% to $0.7693 after surging over 50% on Monday.
  • Chijet Motor Company, Inc. (NASDAQ:CJET) fell 21.3% to $4.6408.
  • Sono Group N.V. (NASDAQ:SEV) fell 20.3% to $0.2432 after gaining around 76% on Monday.
  • Better Choice Company Inc. (NYSE:BTTR) fell 19.1% to $0.2039.
  • MultiMetaVerse Holdings Limited (NASDAQ:MMV) dropped 18.2% to $1.80.
  • Nevro Corp. (NYSE:NVRO) dropped 17% to $22.85. Several analysts cut their price targets on the stock.
  • Appreciate Holdings, Inc. (NASDAQ:SFR) fell 15.5% to $0.2463.
  • Coinbase Global, Inc. (NASDAQ:COIN) fell 14.3% to $50.41 after the SEC sued the company in NY federal court.
  • Leap Therapeutics, Inc. (NASDAQ:LPTX) declined 14.4% to $0.7248.
  • Wearable Devices Ltd. (NASDAQ:WLDS) fell 14% to $1.84.
  • WeWork Inc. (NYSE:WE) fell 12.1% to $0.2015.
  • Bausch Health Companies Inc. (NYSE:BHC) dropped 11.9% to $6.99.
  • Ciena Corporation (NYSE:CIEN) fell 11.5% to $42.06 following second-quarter results.
  • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) fell 10% to $0.2050. Bluejay Diagnostics filed for mixed shelf of up to $25 million.
  • Blue Bird Corporation (NASDAQ:BLBD) dipped 8.4% to $23.03. Blue Bird announced a secondary public offering of 5 million shares.
  • Pasithea Therapeutics Corp (NASDAQ:KTTA) shares dropped 7.6% to $0.4622. Pasithea Therapeutics shares jumped 25% on Monday after Lucy Scientific Discovery proposed to acquire the company for $0.60 per share in cash and $0.25 per share in Lucy stock.
  • View, Inc. (NASDAQ:VIEW) fell 6.7% to $0.1817. View announced plans for reverse stock split to ensure full compliance with Nasdaq listing rules.

 

Now Read This: Ethereum Drops But Remains Above $1,800; Sandbox, Pepe Among Top Losers


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasBiotechnologyHealth CareMid-Day MoversTop Gainers